HLS Therapeutics Appoints Linda Maxwell, Mark DeLong as Independent Directors

PUBT · 1d ago
HLS Therapeutics Appoints Linda Maxwell, Mark DeLong as Independent Directors
  • HLS Therapeutics appointed Dr. Linda Maxwell and Mark DeLong as independent directors, effective October 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLS Therapeutics Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611120700CANADANWCANADAPR_C6790) on November 12, 2026, and is solely responsible for the information contained therein.